Literature DB >> 765327

Total synthesis of the structural gene for the precursor of a tyrosine suppressor transfer RNA from Escherichia coli. 1. General introduction.

H G Khorana, K L Agarwal, P Besmer, H Büchi, M H Caruthers, P J Cashion, M Fridkin, E Jay, K Kleppe, R Kleppe, A Kumar, P C Loewen, R C Miller, K Minamoto, A Panet, U L RajBhandary, B Ramamoorthy, T Sekiya, T Takeya, J H van de Sande.   

Abstract

With the ultimate objective of the total synthesis of a tRNA gene including its transcriptional signals, an Escherichia coli tyrosine suppressor tRNA gene was chosen. The arguments in favor of this choice are presented. A plan for the total synthesis of the 126-nucleotide-long DNA duplex corresponding to a precursor (Altman S., and Smith, J. D. (1971) Nature New Biol. 233, 35) to the above tRNA is formulated. The plan involves: (a) the chemical synthesis of 26 deoxyribooligonucleotide segments, (b) polynucleotide ligase-catalyzed joining of several segments at a time to form a total of four DNA duplexes with appropriate comlementary single-stranded ends, and (c) the joining of the duplexes to form the entire DNA duplex. Ten accompanying papers describe the experimental realization of this objective.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 765327

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Promoter mutations in the transfer RNA gene tyrT of Escherichia coli.

Authors:  M L Berman; A Landy
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

Review 2.  Genome engineering.

Authors:  Peter A Carr; George M Church
Journal:  Nat Biotechnol       Date:  2009-12       Impact factor: 54.908

3.  Chemical synthesis of the hexanucleotide d(A-C-C-A-G-C) required to isolate fibroin mRNA on an affinity column.

Authors:  P Cashion; H Notman; G Sathe; T Cadger; K Porter; E Jay
Journal:  Nucleic Acids Res       Date:  1977-08       Impact factor: 16.971

4.  Studies of gene control regions. III. Binding of synthetic and modified synthetic lac operator DNAs to lactose repressor.

Authors:  D G Yansura; D V Goeddel; D L Cribbs; M H Caruthers
Journal:  Nucleic Acids Res       Date:  1977-03       Impact factor: 16.971

5.  Synthesis of human insulin gene. Part I. Development of reversed-phase chromatography in the modified triester method. Its application in the rapid and efficient synthesis of eight deoxyribooligonucleotides fragments constituting human insulin A DNA.

Authors:  H M Hsiung; R Brousseau; J Michniewicz; S A Narang
Journal:  Nucleic Acids Res       Date:  1979-04       Impact factor: 16.971

6.  Synthesis of the human insulin gene. Part II. Further improvements in the modified phosphotriester method and the synthesis of seventeen deoxyribooligonucleotide fragments constituting human insulin chains B and mini-CDNA.

Authors:  W L Sung; H M Hsiung; R Brousseau; J Michniewicz; R Wu; S A Narang
Journal:  Nucleic Acids Res       Date:  1979-12-20       Impact factor: 16.971

7.  Rapid synthesis of oligodeoxyribonucleotides: a new solid-phase method.

Authors:  M J Gait; R C Sheppard
Journal:  Nucleic Acids Res       Date:  1977-04       Impact factor: 16.971

8.  The effect of antibiotics on the T4 polynucleotide ligase catalyzed template dependent polymerization of oligodeoxythymidylates.

Authors:  B W Kalisch; J H van de Sande
Journal:  Nucleic Acids Res       Date:  1979       Impact factor: 16.971

9.  Chemical synthesis of a self-complementary octanucleotide, dG-G-T-T-A-A-C-C by a modified triester method.

Authors:  K L Agarwal; F Riftina
Journal:  Nucleic Acids Res       Date:  1978-08       Impact factor: 16.971

10.  Synthesis of the human insulin gene. Part III. Chemical synthesis of 5'-phosphomonoester group containing deoxyribooligonucleotides by the modified phosphotriester method. Its application in the synthesis of seventeen fragments constituting human insulin C-chain DNA.

Authors:  H M Hsiung; W L Sung; R Brousseau; R Wu; S A Narang
Journal:  Nucleic Acids Res       Date:  1980-12-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.